Results 31 to 40 of about 309,396 (215)
Serous cystic neoplasms of the pancreas are rare exocrine pancreatic neoplasms, most of which are benign and do not communicate with the pancreatic duct.
Aya Kawanishi +11 more
doaj +1 more source
Exosomal miRNA signatures of pancreatic lesions
Background Pancreatic and peri-pancreatic neoplasms encompass a variety of histotypes characterized by a heterogeneous prognostic impact. miRNAs are considered efficient candidate biomarkers due to their high stability in tissues and body fluids.
Caterina Vicentini +11 more
doaj +1 more source
Advanced Imaging of Pancreatic Neoplasms
Imaging has a pivotal role in pancreatic neoplasms, ranging from diagnosis to treatment monitor. It is crucial, especially for pancreatic ductal adenocarcinoma (PDAC), to obtain an early diagnosis, since the therapeutic approach is mainly surgical and ...
Cardobi N., De Robertis R., D'Onofrio M.
core +1 more source
Despite the increasing rate of detection of incidental pancreatic cystic lesions (PCLs), current standard-of-care methods for their diagnosis and risk stratification remain inadequate.
Joanna Jiang +12 more
doaj +1 more source
Neuroendocrine NeoplasmsImaging and Pathology of Pancreatic Neoplasms
Although interest in pancreatic pathology is very high in the radiological and gastroenterological communities, it is still the case that less is known about pathology of the pancreas than about liver pathology, for example.
Matteo Fassan +17 more
core +1 more source
Objective: Intraductal papillary mucinous neoplasm (IPMN) is a rare pancreatic lesion. The identification of malignancy is critical for the establishment of treatment strategies.
Huifeng Zhang PhD +8 more
doaj +1 more source
Although interest in pancreatic pathology is very high in the radiological and gastroenterological communities, it is still the case that less is known about pathology of the pancreas than about liver pathology, for example.
Valentina Ciaravino +11 more
core +1 more source
Management of intraductal papillary and mucinous pancreatic neoplasms
Management of intraductal papillary and mucinous pancreatic neoplasms. Mucinous and papillary pancreatic cystic neoplasm is a controversial pathology both from a diagnostic point of view and from a management point of view. These recommendations will include diagnostic modalities and criteria (endoscopic, imaging and histopathological), conservative ...
Alexandru Năstase +9 more
openaire +1 more source
Is GLP-1 receptor agonist therapy safe for patients with intraductal papillary mucinous neoplasm?
Glucagon-like peptide-1 receptor agonists are increasingly used in the management of obesity and diabetes. Their potential risks, however, particularly regarding pancreatitis and pancreatic cancer, remain contentious.
Melissa Lagger +4 more
doaj +1 more source
Pancreatic Cystic Lesions: Pathogenesis and Malignant Potential
Pancreatic cancer remains one of the most lethal cancers despite extensive research. Further understanding of precursor lesions may enhance the ability to treat and prevent pancreatic cancer.
Antoinette J. Pusateri +1 more
doaj +1 more source

